Research ExplorerScientific StaffJasmin Wellbrock Publications

Jasmin Wellbrock

graph of relations
Affiliations
1 - 50 out of 54Page size: 50

Publications

  1. 2023

  2. Single-cell transcriptomic atlas-guided development of CAR-T cells for the treatment of acute myeloid leukemia

    Gottschlich, A., Thomas, M., Grünmeier, R., Lesch, S., Rohrbacher, L., Igl, V., Briukhovetska, D., Benmebarek, M-R., Vick, B., Dede, S., Müller, K., Xu, T., Dhoqina, D., Märkl, F., Robinson, S., Sendelhofert, A., Schulz, H., Umut, Ö., Kavaka, V., Tsiverioti, C. A., Carlini, E., Nandi, S., Strzalkowski, T., Lorenzini, T., Stock, S., Müller, P. J., Dörr, J., Seifert, M., Cadilha, B. L., Brabenec, R., Röder, N., Rataj, F., Nüesch, M., Modemann, F., Wellbrock, J., Fiedler, W., Kellner, C., Beltrán, E., Herold, T., Paquet, D., Jeremias, I., von Baumgarten, L., Endres, S., Subklewe, M., Marr, C. & Kobold, S., 11.2023, In: NAT BIOTECHNOL. 41, 11, p. 1618-1632 15 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. Immunosuppressive M2 TAMs represent a promising target population to enhance phagocytosis of ovarian cancer cells in vitro

    Brauneck, F., Schmalfeldt, B., Muschhammer, J., Sturmheit, T., Ackermann, C., Haag, F., Schulze Zur Wiesch, J., Ding, Y., Qi, M., Hell, L., Schmalfeldt, B., Bokemeyer, C., Fiedler, W. & Wellbrock, J., 2023, In: FRONT IMMUNOL. 14, p. 1250258

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  4. 2022

  5. TIGIT blockade repolarizes AML-associated TIGIT+ M2 macrophages to an M1 phenotype and increases CD47-mediated phagocytosis

    Brauneck, F., Fischer, B., Witt, M., Muschhammer, J., Oelrich, J., da Costa Avelar, P. H., Tsoka, S., Bullinger, L., Seubert, E., Smit, D. J., Bokemeyer, C., Ackermann, C., Wellbrock, J., Haag, F. & Fiedler, W., 12.2022, In: J IMMUNOTHER CANCER. 10, 12, e004794.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  6. Mebendazole's Conformational Space and Its Predicted Binding to Human Heat-Shock Protein 90

    Fiedler, W., Freisleben, F., Wellbrock, J. & Kirschner, K. N., 08.08.2022, In: J CHEM INF MODEL. 62, 15, p. 3604-3617 14 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  7. Tissue-Specific Expression of TIGIT, PD-1, TIM-3, and CD39 by γδ T Cells in Ovarian Cancer

    Weimer, P., Wellbrock, J., Sturmheit, T., Ferrer, L. O., Ding, Y., Menzel, S., Witt, M., Hell, L., Schmalfeldt, B., Bokemeyer, C., Fiedler, W. & Brauneck, F., 11.03.2022, In: CELLS-BASEL. 11, 6, 964.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  8. 2021

  9. The BET bromodomain inhibitor ZEN-3365 targets the Hedgehog signaling pathway in acute myeloid leukemia

    Wellbrock, J., Behrmann, L., Muschhammer, J., Modemann, F., Khoury, K., Brauneck, F., Bokemeyer, C., Campeau, E. & Fiedler, W., 12.2021, In: ANN HEMATOL. 100, 12, p. 2933-2941 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  10. Combined Blockade of TIGIT and CD39 or A2AR Enhances NK-92 Cell-Mediated Cytotoxicity in AML

    Brauneck, F., Seubert, E., Wellbrock, J., Schulze Zur Wiesch, J., Duan, Y., Magnus, T., Bokemeyer, C., Koch-Nolte, F., Menzel, S. & Fiedler, W., 29.11.2021, In: INT J MOL SCI. 22, 23, 12919.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  11. Bone Marrow-Resident Vδ1 T Cells Co-express TIGIT With PD-1, TIM-3 or CD39 in AML and Myeloma

    Brauneck, F., Weimer, P., Schulze zur Wiesch, J., Weisel, K. C., Leypoldt, L. B., Vohwinkel, G., Fritzsche, B., Bokemeyer, C., Wellbrock, J. & Fiedler, W., 08.11.2021, In: FRONT MED-LAUSANNE. 8, p. 763773 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  12. Mebendazole Mediates Proteasomal Degradation of GLI Transcription Factors in Acute Myeloid Leukemia

    Freisleben, F., Modemann, F., Muschhammer, J., Stamm, H., Brauneck, F., Krispien, A., Bokemeyer, C., Kirschner, K. N., Wellbrock, J. & Fiedler, W., 01.10.2021, In: INT J MOL SCI. 22, 19, p. 10670

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  13. Increased frequency of TIGIT+CD73-CD8+ T cells with a TOX+ TCF-1low profile in patients with newly diagnosed and relapsed AML

    Brauneck, F., Haag, F., Woost, R., Wildner, N., Tolosa, E., Rissiek, A., Vohwinkel, G., Wellbrock, J., Bokemeyer, C., Schulze Zur Wiesch, J., Ackermann, C. & Fiedler, W., 21.06.2021, In: ONCOIMMUNOLOGY. 10, 1, p. 1930391

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  14. High Mobility Group Box 1 (HMGB1) Induces Toll-Like Receptor 4-Mediated Production of the Immunosuppressive Protein Galectin-9 in Human Cancer Cells

    Teo Hansen Selnø, A., Schlichtner, S., Yasinska, I. M., Sakhnevych, S. S., Fiedler, W., Wellbrock, J., Berger, S. M., Klenova, E., Gibbs, B. F., Fasler-Kan, E. & Sumbayev, V. V., 2021, In: FRONT IMMUNOL. 12, 675731.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  15. 2020

  16. Transforming growth factor beta type 1 (TGF-β) and hypoxia-inducible factor 1 (HIF-1) transcription complex as master regulators of the immunosuppressive protein galectin-9 expression in human cancer and embryonic cells

    Selnø, A. T. H., Schlichtner, S., Yasinska, I. M., Sakhnevych, S. S., Fiedler, W., Wellbrock, J., Klenova, E., Pavlova, L., Gibbs, B. F., Degen, M., Schnyder, I., Aliu, N., Berger, S. M., Fasler-Kan, E. & Sumbayev, V. V., 08.12.2020, In: AGING-US. 12, 23, p. 23478-23496 19 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  17. Ligand-Receptor Interactions of Galectin-9 and VISTA Suppress Human T Lymphocyte Cytotoxic Activity

    Yasinska, I. M., Meyer, N. H., Schlichtner, S., Hussain, R., Siligardi, G., Casely-Hayford, M., Fiedler, W., Wellbrock, J., Desmet, C., Calzolai, L., Varani, L., Berger, S. M., Raap, U., Gibbs, B. F., Fasler-Kan, E. & Sumbayev, V. V., 20.11.2020, In: FRONT IMMUNOL. 11, p. 580557

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  18. Downregulation of GLI3 Expression Mediates Chemotherapy Resistance in Acute Myeloid Leukemia

    Freisleben, F., Behrmann, L., Thaden, V., Muschhammer, J., Bokemeyer, C., Fiedler, W. & Wellbrock, J., 18.07.2020, In: INT J MOL SCI. 21, 14

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  19. The bone marrow stromal niche: a therapeutic target of hematological myeloid malignancies

    Behrmann, L., Wellbrock, J. & Fiedler, W., 05.2020, In: EXPERT OPIN THER TAR. 24, 5, p. 451-462 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  20. Mechanisms of Tumor-Lymphatic Interactions in Invasive Breast and Prostate Carcinoma

    Oliveira-Ferrer, L., Milde-Langosch, K., Eylmann, K., Rossberg, M., Müller, V., Schmalfeldt, B., Witzel, I., Wellbrock, J. & Fiedler, W., 17.01.2020, In: INT J MOL SCI. 21, 2

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  21. Preclinical Quantification of Prostate Cancer-Associated Vascular Alterations in the Bone Microenvironment in vivo

    Schroeder, M., Viezens, L., Sündermann, J., Hettenhausen, S., Hauenherm, G., Wellbrock, J., Mussawy, H., Kossow, K. & Schaefer, C., 2020, In: EUR SURG RES. 61, 6, p. 188-200 13 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  22. 2019

  23. The Actin Binding Protein Plastin-3 Is Involved in the Pathogenesis of Acute Myeloid Leukemia

    Velthaus, A., Cornils, K., Hennigs, J. K., Grüb, S., Stamm, H., Wicklein, D., Bokemeyer, C., Heuser, M., Windhorst, S., Fiedler, W. & Wellbrock, J., 26.10.2019, In: CANCERS. 11, 11

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  24. 3D in vitro system for measuring treatment responses to immunotherapy in CRC patients

    Sturmheit, T., Stamm, H., Sutus Temovski, T., Konczalla, L., Brauneck, F., Stange, I., Köllmann, S., Li, J., Perez, D., thastrup, J., Wellbrock, J., Fiedler, W., Kupper, J. & Block, A., 2019, In: J CLIN ONCOL.

    Research output: SCORING: Contribution to journal › Conference abstract in journal › Research › peer-review

  25. Targeting the TIGIT-PVR immune checkpoint axis as novel therapeutic option in breast cancer

    Stamm, H., Oliveira-Ferrer, L., Grossjohann, E-M., Muschhammer, J., Thaden, V., Brauneck, F., Kischel, R., Müller, V., Bokemeyer, C., Fiedler, W. & Wellbrock, J., 2019, In: ONCOIMMUNOLOGY. 8, 12, p. e1674605

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  26. 2018

  27. Development and Characterization of a Spontaneously Metastatic Patient-Derived Xenograft Model of Human Prostate Cancer

    Lange, T., Oh-Hohenhorst, S. J., Joosse, S. A., Pantel, K., Hahn, O., Gosau, T., Dyshlovoy, S. A., Wellbrock, J., Feldhaus, S., Maar, H., Gehrcke, R., Kluth, M., Simon, R., Schlomm, T., Huland, H. & Schumacher, U., 03.12.2018, In: SCI REP-UK. 8, p. 17535

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  28. Interaction of PVR/PVRL2 with TIGIT/DNAM-1 as a novel immune checkpoint axis and therapeutic target in cancer

    Stamm, H., Wellbrock, J. & Fiedler, W., 12.2018, In: MAMM GENOME. 29, 11-12, p. 694-702 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  29. Acute Myeloid Leukemia and the Bone Marrow Niche-Take a Closer Look

    Behrmann, L., Wellbrock, J. & Fiedler, W., 18.11.2018, In: FRONT ONCOL. 8, p. 444

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  30. Cortisol facilitates the immune escape of human acute myeloid leukemia cells by inducing latrophilin 1 expression

    Sakhnevych, S. S., Yasinska, I. M., Bratt, A. M., Benlaouer, O., Gonçalves Silva, I., Hussain, R., Siligardi, G., Fiedler, W., Wellbrock, J., Gibbs, B. F., Ushkaryov, Y. A. & Sumbayev, V. V., 11.2018, In: CELL MOL IMMUNOL. 15, 11, p. 994-997 4 p.

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  31. The bone microenvironment promotes tumor growth and tissue perfusion compared with striated muscle in a preclinical model of prostate cancer in vivo

    Mussawy, H., Viezens, L., Schröder, M., Hettenhausen, S., Sündermann, J., Wellbrock, J., Kossow, K. & Schäfer, C., 16.10.2018, In: BMC CANCER. 18, 1, p. 979

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  32. Immune checkpoints PVR and PVRL2 are prognostic markers in AML and their blockade represents a new therapeutic option

    Stamm, H., Klingler, F., Grossjohann, E-M., Muschhammer, J., Vettorazzi, E., Heuser, M., Mock, U., Thol, F., Vohwinkel, G., Latuske, E., Bokemeyer, C., Kischel, R., Dos Santos, C., Stienen, S., Friedrich, M., Lutteropp, M., Nagorsen, D., Wellbrock, J. & Fiedler, W., 09.2018, In: ONCOGENE. 37, 39, p. 5269-5280 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  33. Effect of the actin- and calcium-regulating activities of ITPKB on the metastatic potential of lung cancer cells

    Bäder, S., Glaubke, E., Grüb, S., Muhs, S., Wellbrock, J., Nalaskowski, M., Lange, T. & Windhorst, S., 26.06.2018, In: BIOCHEM J. 475, 12, p. 2057-2071 15 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  34. Highly specific targeting of human acute myeloid leukaemia cells using pharmacologically active nanoconjugates

    Yasinska, I. M., Ceccone, G., Ojea-Jimenez, I., Ponti, J., Hussain, R., Siligardi, G., Berger, S. M., Fasler-Kan, E., Bardelli, M., Varani, L., Fiedler, W., Wellbrock, J., Raap, U., Gibbs, B. F., Calzolai, L. & Sumbayev, V. V., 29.03.2018, In: NANOSCALE. 10, 13, p. 5827-5833 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  35. High mobility group box 1 (HMGB1) acts as an "alarmin" to promote acute myeloid leukaemia progression

    Yasinska, I. M., Gonçalves Silva, I., Sakhnevych, S. S., Ruegg, L., Hussain, R., Siligardi, G., Fiedler, W., Wellbrock, J., Bardelli, M., Varani, L., Raap, U., Berger, S., Gibbs, B. F., Fasler-Kan, E. & Sumbayev, V. V., 2018, In: ONCOIMMUNOLOGY. 7, 6, p. e1438109

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  36. 2017

  37. RUNX1 Upregulation by Cytotoxic Drugs Promotes Apoptosis

    Speidel, D., Wellbrock, J. & Abas, M., 15.12.2017, In: CANCER RES. 77, 24, p. 6818-6824 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  38. Strong fascin expression promotes metastasis independent of its F-actin bundling activity

    Heinz, L. S., Muhs, S., Schiewek, J., Grüb, S., Nalaskowski, M., Lin, Y-N., Wikman, H., Oliveira-Ferrer, L., Lange, T., Wellbrock, J., Konietzny, A., Mikhaylova, M. & Windhorst, S., 15.12.2017, In: ONCOTARGET. 8, 66, p. 110077-110091 15 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  39. SHIP1, but not an AML-derived SHIP1 mutant, suppresses myeloid leukemia growth in a xenotransplantation mouse model

    Täger, M., Horn, S., Latuske, E., Ehm, P., Schaks, M., Nalaskowski, M., Fehse, B., Fiedler, W., Stocking, C., Wellbrock, J. & Jücker, M., 11.2017, In: GENE THER. 24, 11, p. 749-753 5 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  40. The Tim-3-galectin-9 Secretory Pathway is Involved in the Immune Escape of Human Acute Myeloid Leukemia Cells

    Gonçalves Silva, I., Yasinska, I. M., Sakhnevych, S. S., Fiedler, W., Wellbrock, J., Bardelli, M., Varani, L., Hussain, R., Siligardi, G., Ceccone, G., Berger, S. M., Ushkaryov, Y. A., Gibbs, B. F., Fasler-Kan, E. & Sumbayev, V. V., 08.2017, In: EBIOMEDICINE. 22, p. 44-57 14 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  41. Comparison between Minimally Invasive Surgery and Conventional Open Surgery for Patients with Spinal Metastasis: A Prospective Propensity Score-Matched Study

    Hansen-Algenstaedt, N., Kwan, M. K., Algenstaedt, P., Chiu, C. K., Viezens, L., Chan, T. S., Lee, C. K., Wellbrock, J., Chan, C. Y. W. & Schaefer, C., 15.05.2017, In: SPINE. 42, 10, p. 789-797

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  42. Combined inhibition of GLI and FLT3 signaling leads to effective anti-leukemic effects in human acute myeloid leukemia

    Latuske, E-M., Stamm, H., Klokow, M., Vohwinkel, G., Muschhammer, J., Bokemeyer, C., Jücker, M., Kebenko, M., Fiedler, W. & Wellbrock, J., 25.04.2017, In: ONCOTARGET. 8, 17, p. 29187-29201

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  43. Relevance of the Hedgehog pathway in T-cell acute lymphoblastic leukemia

    Wellbrock, J. & Fiedler, W., 02.03.2017, In: TRANSL CANCER RES. 6, Suppl 2, p. 286-291

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  44. 2016

  45. Deoxycytidine kinase is downregulated under hypoxic conditions and confers resistance against cytarabine in acute myeloid leukaemia

    Degwert, N., Latuske, E., Vohwinkel, G., Stamm, H., Klokow, M., Bokemeyer, C., Fiedler, W. & Wellbrock, J., 09.2016, In: EUR J HAEMATOL. 97, 3, p. 239-44

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  46. Sunitinib treatment reduces tumor growth and limits changes in microvascular properties after minor surgical intervention in an in vivo model of secondary breast cancer growth in bone

    Schroeder, M., Viezens, L., Wellbrock, J., Fiedler, W., Ruether, W., Algenstaedt, P., Hansen-Algenstaedt, N. & Schäfer, C., 04.2016, In: J SURG ONCOL. 113, 5, p. 515-21

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  47. 2015

  48. Intrinsic BMP Antagonist Gremlin-1 as a Novel Circulating Marker in Pulmonary Arterial Hypertension

    Wellbrock, J., Harbaum, L., Stamm, H., Hennigs, J. K., Schulz, B., Klose, H., Bokemeyer, C., Fiedler, W. & Lüneburg, N., 30.04.2015, In: LUNG.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  49. Expression of Hedgehog Pathway Mediator GLI Represents a Negative Prognostic Marker in Human Acute Myeloid Leukemia and Its Inhibition Exerts Antileukemic Effects

    Wellbrock, J., Latuske, E., Köhler, J., Wagner, K., Stamm, H., Vettorazzi, E., Vohwinkel, G., Klokow, M., Uibeleisen, R., Ehm, P., Riecken, K., Loges, S., Thol, F., Schubert, C., Amling, M., Jücker, M., Bokemeyer, C., Heuser, M., Krauter, J. & Fiedler, W., 05.03.2015, In: CLIN CANCER RES.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  50. ErbB2 signaling activates the Hedgehog pathway via PI3K-Akt in human esophageal adenocarcinoma: Identification of novel targets for concerted therapy concepts

    Kebenko, M., Drenckhan, A., Gros, S. J., Jücker, M., Grabinski, N., Ewald, F., Grottke, A., Schultze, A., Izbicki, J. R., Bokemeyer, C., Wellbrock, J. & Fiedler, W., 01.02.2015, In: CELL SIGNAL. 27, 2, p. 373-81 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  51. 2014

  52. New antiangiogenic strategies beyond inhibition of vascular endothelial growth factor with special focus on axon guidance molecules

    Pircher, A., Wellbrock, J., Fiedler, W., Heidegger, I., Gunsilius, E. & Hilbe, W., 01.01.2014, In: NEURO-ONCOLOGY. 86, 1, p. 46-52 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  53. Overexpression of Gremlin-1 in Patients with Loeys-Dietz Syndrome: Implications on Pathophysiology and Early Disease Detection

    Wellbrock, J., Sheikhzadeh, S., Oliveira Ferrer, L., Stamm, H., Hillebrand, M., Keyser, B., Klokow, M., Vohwinkel, G., Bonk, V., Otto, B., Streichert, T., Balabanov, S., Hagel, C., Rybczynski, M., Bentzien, F., Bokemeyer, C., Kodolitsch, Y. & Fiedler, W., 01.01.2014, In: PLOS ONE. 9, 8, p. e104742

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  54. 2013

  55. Axl, a prognostic and therapeutic target in acute myeloid leukemia mediates paracrine crosstalk of leukemia cells with bone marrow stroma

    Ben Batalla, I., Schultze, A., Wroblewski, M., Erdmann, R., Heuser, M., Waizenegger, J. S., Riecken, K., Binder, M., Schewe, D., Sawall, S., Witzke, V., Cubas Cordova, M., Janning, M., Wellbrock, J., Fehse, B., Hagel, C., Krauter, J., Ganser, A., Lorens, J. B., Fiedler, W., Carmeliet, P., Pantel, K., Bokemeyer, C. & Loges, S., 03.10.2013, In: BLOOD. 122, 14, p. 2443-52 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  56. Combination therapy targeting integrins reduces glioblastoma tumor growth through antiangiogenic and direct antitumor activity and leads to activation of the pro-proliferative prolactin pathway

    Oliveira Ferrer, L., Wellbrock, J., Bartsch, U., Penas, E. M. M., Hauschild, J., Klokow, M., Bokemeyer, C., Fiedler, W. & Schuch, G., 01.01.2013, In: MOL CANCER. 12, 1, p. 144

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  57. 2012

  58. CD146: a new partner for VEGFR2.

    Wellbrock, J. & Fiedler, W., 2012, In: BLOOD. 120, 11, p. 2164-2165 11.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  59. The metabolite 3-hydroxiglutaric acid effectively reduces glioblastoma growth in vivo by affecting the structural integrity of tumor vasculature.

    Oliveira-Ferrer, L., Wellbrock, J., Balabanov, M., Klockow, M., Hauschild, J., Bokemeyer, C., Fiedler, W., Ergun, S. & Schuch, G., 2012, In: CANCER LETT. 326, 2, p. 161-167 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  60. 2011

  61. Clinical experience with antiangiogenic therapy in leukemia.

    Wellbrock, J. & Fiedler, W., 2011, In: CURR CANCER DRUG TAR. 11, 9, p. 1053-1068 9.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  62. Primary tumor dependent inhibition of tumor growth, Angio-Genesis, and perfusion of secondary breast cancer in bone.

    Schäfer, C., Schröder, M., Fuhrhop, I., Viezens, L., Wellbrock, J., Fiedler, W., Rüther, W. & Hansen-Algenstaedt, N., 2011, In: J ORTHOP RES. 29, 8, p. 1251-1258 8.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  63. 2010

  64. Microcirculation of secondary bone tumors in vivo: the impact of minor surgery at a distal site.

    Schäfer, C., Fuhrhop, I., Schröder, M., Viezens, L., Wellbrock, J., Fiedler, W., Rüther, W. & Hansen-Algenstaedt, N., 2010, In: J ORTHOP RES. 28, 11, p. 1515-1521 11.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Previous 1 2 Next